BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23919303)

  • 1. Novel 1H-pyrrolo[2,3-b]pyridine derivative nortopsentin analogues: synthesis and antitumor activity in peritoneal mesothelioma experimental models.
    Carbone A; Pennati M; Parrino B; Lopergolo A; Barraja P; Montalbano A; Spanò V; Sbarra S; Doldi V; De Cesare M; Cirrincione G; Diana P; Zaffaroni N
    J Med Chem; 2013 Sep; 56(17):7060-72. PubMed ID: 23919303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antiproliferative activity of substituted 3[2-(1H-indol-3-yl)- 1,3-thiazol-4-yl]-1H-pyrrolo[3,2-b]pyridines, marine alkaloid nortopsentin analogues.
    Carbone A; Pennati M; Barraja P; Montalbano A; Parrino B; Spanò V; Lopergolo A; Sbarra S; Doldi V; Zaffaroni N; Cirrincione G; Diana P
    Curr Med Chem; 2014; 21(14):1654-66. PubMed ID: 24180279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-[4-(1H-indol-3-yl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridines, nortopsentin analogues with antiproliferative activity.
    Parrino B; Carbone A; Di Vita G; Ciancimino C; Attanzio A; Spanò V; Montalbano A; Barraja P; Tesoriere L; Livrea MA; Diana P; Cirrincione G
    Mar Drugs; 2015 Apr; 13(4):1901-24. PubMed ID: 25854642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell division cycle 7 kinase inhibitors: 1H-pyrrolo[2,3-b]pyridines, synthesis and structure-activity relationships.
    Ermoli A; Bargiotti A; Brasca MG; Ciavolella A; Colombo N; Fachin G; Isacchi A; Menichincheri M; Molinari A; Montagnoli A; Pillan A; Rainoldi S; Sirtori FR; Sola F; Thieffine S; Tibolla M; Valsasina B; Volpi D; Santocanale C; Vanotti E
    J Med Chem; 2009 Jul; 52(14):4380-90. PubMed ID: 19555113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamics of 2-[4-[(1E)-1-(hydroxyimino)-2,3-dihydro-1H-inden-5-yl]-3-(pyridine-4-yl)-1H-pyrazol-1-yl]ethan-1-ol (GDC-0879), a potent and selective B-Raf kinase inhibitor: understanding relationships between systemic concentrations, phosphorylated mitogen-activated protein kinase kinase 1 inhibition, and efficacy.
    Wong H; Belvin M; Herter S; Hoeflich KP; Murray LJ; Wong L; Choo EF
    J Pharmacol Exp Ther; 2009 Apr; 329(1):360-7. PubMed ID: 19147858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma.
    Sciarrillo R; Wojtuszkiewicz A; El Hassouni B; Funel N; Gandellini P; Lagerweij T; Buonamici S; Blijlevens M; Zeeuw van der Laan EA; Zaffaroni N; Deraco M; Kusamura S; Würdinger T; Peters GJ; Molthoff CFM; Jansen G; Kaspers GJL; Cloos J; Giovannetti E
    EBioMedicine; 2019 Jan; 39():215-225. PubMed ID: 30581150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SYNTHESIS AND BIOLOGICAL ACTIVITY OF NOVEL 6-PHENYL-1H-PYRROLO[3,4-c]PYRIDINE-1,3-DIONE DERIVATIVES.
    Wojcicka A; Becan L; Junka A; Brtoszewicz M; Secewicz A; Trynda J; Wietrzyk J
    Acta Pol Pharm; 2017 Mar; 74(2):435-443. PubMed ID: 29624249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel 5,7-disubstituted 6-amino-5H-pyrrolo[3,2-b]pyrazine-2,3-dicarbonitriles, the promising protein kinase inhibitors with antiproliferative activity.
    Dubinina GG; Platonov MO; Golovach SM; Borysko PO; Tolmachov AO; Volovenko YM
    Eur J Med Chem; 2006 Jun; 41(6):727-37. PubMed ID: 16675067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of pyrazolo[3,4-b]pyridines under microwave irradiation in multi-component reactions and their antitumor and antimicrobial activities - Part 1.
    El-borai MA; Rizk HF; Abd-Aal MF; El-Deeb IY
    Eur J Med Chem; 2012 Feb; 48():92-6. PubMed ID: 22178093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological activity of 3- and 5-amino derivatives of pyridine-2-carboxaldehyde thiosemicarbazone.
    Liu MC; Lin TS; Cory JG; Cory AH; Sartorelli AC
    J Med Chem; 1996 Jun; 39(13):2586-93. PubMed ID: 8691457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CpG-oligodeoxynucleotides exert remarkable antitumor activity against diffuse malignant peritoneal mesothelioma orthotopic xenografts.
    De Cesare M; Sfondrini L; Pennati M; De Marco C; Motta V; Tagliabue E; Deraco M; Balsari A; Zaffaroni N
    J Transl Med; 2016 Jan; 14():25. PubMed ID: 26810896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antiproliferative activity of pyrrolo[3,2-b]pyridine derivatives against melanoma.
    Kim HJ; Jung MH; Kim H; El-Gamal MI; Sim TB; Lee SH; Hong JH; Hah JM; Cho JH; Choi JH; Yoo KH; Oh CH
    Bioorg Med Chem Lett; 2010 Jan; 20(1):413-7. PubMed ID: 19897366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and antiproliferative activity of new 1H-pyrrolo[3,2-c]pyridine derivatives against melanoma cell lines.
    El-Gamal MI; Jung MH; Lee WS; Sim T; Yoo KH; Oh CH
    Eur J Med Chem; 2011 Aug; 46(8):3218-26. PubMed ID: 21592628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synthesis of 3,5,6,7-tetrasubstituted isoxazolo[4,5-b]pyridines and an evaluation of their in vitro antiproliferative activity.
    Poreba K; Wietrzyk J
    Adv Clin Exp Med; 2012; 21(5):563-71. PubMed ID: 23356192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antiproliferative activity in vitro of new 3-substituted aminoisoxazolo[5,4-b]pyridines.
    Poreba K; Wietrzyk J; Opolski A
    Acta Pol Pharm; 2003; 60(4):293-301. PubMed ID: 14714858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antiproliferative activity in vitro of new pyrido[1,4-b]diazepine derivatives and imidazo[4,5-b]pyridine.
    Liszkiewicz H; Nawrocka WP; Sztuba B; Wietrzyk J; Jaroszewicz J; Nasulewicz A; Pełczyńska M
    Acta Pol Pharm; 2011; 68(3):349-55. PubMed ID: 21648189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel inhibitors of epidermal growth factor receptor: (4-(Arylamino)-7H-pyrrolo[2,3-d]pyrimidin-6-yl)(1H-indol-2-yl)methanones and (1H-indol-2-yl)(4-(phenylamino)thieno[2,3-d]pyrimidin-6-yl)methanones.
    Beckers T; Sellmer A; Eichhorn E; Pongratz H; Schächtele C; Totzke F; Kelter G; Krumbach R; Fiebig HH; Böhmer FD; Mahboobi S
    Bioorg Med Chem; 2012 Jan; 20(1):125-36. PubMed ID: 22169601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical Activity of New [1,2]Oxazolo[5,4-e]isoindole Derivatives in Diffuse Malignant Peritoneal Mesothelioma.
    Spanò V; Pennati M; Parrino B; Carbone A; Montalbano A; Cilibrasi V; Zuco V; Lopergolo A; Cominetti D; Diana P; Cirrincione G; Barraja P; Zaffaroni N
    J Med Chem; 2016 Aug; 59(15):7223-38. PubMed ID: 27428868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel 1-(azacyclyl)-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines as 5-HT6 agonists and antagonists.
    Elokdah H; Li D; McFarlane G; Bernotas RC; Robichaud AJ; Magolda RL; Zhang GM; Smith D; Schechter LE
    Bioorg Med Chem; 2007 Sep; 15(18):6208-26. PubMed ID: 17624788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simple and convenient approach to the Kreohnke pyridine type synthesis of functionalized indol-3-yl pyridine derivatives using 3-cyanoacetyl indole.
    Thirumurugan P; Nandakumar A; Muralidharan D; Perumal PT
    J Comb Chem; 2010; 12(1):161-7. PubMed ID: 19905001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.